Recent advances of α-glucosidase inhibitors: A comprehensive review

N Agrawal, M Sharma, S Singh… - Current topics in …, 2022 - ingentaconnect.com
Background: Diabetes mellitus (DM) is a critical health issue prevailing in nearly half a
billion people worldwide. It is one of the most threatening metabolic diseases. Type 2 DM is …

Bio-oriented synthesis of novel polyhydroquinoline derivatives as α-glucosidase inhibitor for management of diabetes

F Talab, S Ullah, A Alam, SA Halim, NU Rehman… - ACS …, 2023 - ACS Publications
Polyhydroquinoline derivatives (1-15) were synthesized through an unsymmetrical Hantzsch
reaction in excellent yields by treating 3, 5-dibromo-4-hydroxybenzaldehyde, dimedone …

Synthesis of new bis (dimethylamino) benzophenone hydrazone for diabetic management: In-vitro and in-silico approach

M Khan, G Ahad, A Alam, S Ullah, A Khan, U Salar… - Heliyon, 2024 - cell.com
Inhibiting α-glucosidase is a reliable method for reducing blood sugar levels in diabetic
individuals. Bis (dimethylamino) benzophenone derivatives 1–27 were synthesized from bis …

Anti-α-glucosidase, SAR analysis, and mechanism investigation of indolo [1, 2-b] isoquinoline derivatives

M Li, L Li, L Lu, X Xu, J Hu, JB Peng - Molecules, 2023 - mdpi.com
To find potential α-glucosidase inhibitors, indolo [1, 2-b] isoquinoline derivatives (1–20)
were screened for their α-glucosidase inhibitory effects. All derivatives presented potential α …

Novel polyhydroquinoline Schiff's base derivatives: synthesis, characterization, in vitro α-glucosidase inhibitory, and molecular docking studies

N Shahab, D Kong, M Ali, A Alam, N Ur Rehman… - Research on Chemical …, 2023 - Springer
Novel Schiff's base hydrazone derivatives (1–24) based on polyhydroquinoline (PHQ) were
synthesized in good to excellent yields via three step reactions. Compound 1 (starting …

Hybrid quinoline-thiosemicarbazone therapeutics as a new treatment opportunity for Alzheimer's disease‒synthesis, in vitro cholinesterase inhibitory potential and …

S Zaib, R Munir, MT Younas, N Kausar, A Ibrar, S Aqsa… - Molecules, 2021 - mdpi.com
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the leading
cause of dementia worldwide. The limited pharmacological approaches based on …

Polyhydroquinoline Derivatives for Diabetic Management: Synthesis, in Vitro and in Silico Approaches

F Talab, Zainab, A Alam, M Ali… - Future Medicinal …, 2023 - Taylor & Francis
Background: Medication used to treat Type 2 diabetes by decreasing the absorption of
carbohydrates in the intestine consists of α-glucosidase inhibitors. Polyhydroquinoline …

Synthesis of new diphenyl urea-clubbed imine analogs and its Implications in diabetic management through in vitro and in silico approaches

AR Pasha, A Khan, S Ullah, SA Halim, J Hussain… - Scientific Reports, 2023 - nature.com
Type II diabetes mellitus (T2DM) is a global health issue with high rate of prevalence. The
inhibition of α-glucosidase enzyme has prime importance in the management of T2DM. This …

New acetylphenol-based acyl thioureas broaden the scope of drug candidates for urease inhibition: synthesis, in vitro screening and in silico analysis

U Zahra, S Zaib, A Saeed, M ur Rehman… - International Journal of …, 2022 - Elsevier
Helicobacter pylori urease remains a validated drug target for the eradication of pervasive
chronic stomach infection that leads to severe human health diseases such as gastritis and …

Novel tetrahydrobenzo [b] thiophen-2-yl) urea derivatives as novel α-glucosidase inhibitors: Synthesis, kinetics study, molecular docking, and in vivo anti …

HX Xie, J Zhang, Y Li, JH Zhang, SK Liu, J Zhang… - Bioorganic …, 2021 - Elsevier
Abstract α-Glucosidase inhibitors, which can inhibit the digestion of carbohydrates into
glucose, are one of important groups of anti-type 2 diabetic drugs. In the present study, we …